The Combination of High Glucose and Advanced Glycation End-products (AGEs) Inhibits the Mineralization of Osteoblastic MC3T3-E1 Cells through Glucose-induced Increase in the Receptor for AGEs.

The Combination of High Glucose and Advanced Glycation End-products (AGEs) Inhibits the Mineralization of Osteoblastic MC3T3-E1 Cells through Glucose-induced Increase in the Receptor for AGEs. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

The Combination of High Glucose and Advanced Glycation End-products (AGEs) Inhibits the Mineralization of Osteoblastic MC3T3-E1 Cells through Glucose-induced Increase in the Receptor for AGEs. Abstract Text:

N Ogawa,T Yamaguchi,S Yano,M Yamauchi,M Yamamoto,T Sugimoto,N Ogawa,T Yamaguchi,S Yano,M Yamauchi,M Yamamoto,T Sugimoto,

Type 1 diabetes mellitus is known to be associated with reduced bone mass and increased bone fractures. This is thought to be due to a decrease in osteoblastic bone formation rather than an increase in osteoclastic bone resorption, but the precise mechanism is unknown. In this study, we examined whether or not high glucose or advanced glycation end-products (AGEs), which play key roles in the pathogenesis and complications of diabetes, affect the differentiation of osteoblastic MC3T3-E1 cells. First, MC3T3-E1 cells were incubated in media containing either 22 mM glucose, 22 mM mannitol, 300 mug/ml AGE2, or 300 mug/ml AGE3. Each of these agents alone did not affect the mineralization of the cells by von Kossa staining and Alizarin red staining. However, high glucose but not mannitol or AGEs markedly increased mRNA expression of AGE receptor (RAGE) by real-time PCR. Next, we examined the combined effects of high glucose and AGEs on the differentiation of MC3T3-E1 cells. The combination of 22 mM glucose and 300 mug/ml AGE2 significantly inhibited the mineralization of MC3T3-E1 cells, and 22 mM glucose in combination with either 300 mug/ml AGE2 or AGE3 apparently decreased osteocalcin mRNA expression. These results suggest that high glucose or AGEs alone might have no effect on osteoblastic differentiation, but their combination could additionally or synergistically inhibit osteoblastic mineralization through glucose-induced increase in RAGE expression.

The Combination of High Glucose and Advanced Glycation End-products (AGEs) Inhibits the Mineralization of Osteoblastic MC3T3-E1 Cells through Glucose-induced Increase in the Receptor for AGEs. Publishing Authors By Initials

N Ogawa,T Yamaguchi,S Yano,M Yamauchi,M Yamamoto,T Sugimoto,N Ogawa,T Yamaguchi,S Yano,M Yamauchi,M Yamamoto,T Sugimoto,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

The Combination of High Glucose and Advanced Glycation End-products (AGEs) Inhibits the Mineralization of Osteoblastic MC3T3-E1 Cells through Glucose-induced Increase in the Receptor for AGEs. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Hormone and metabolic research. Hormon- und Stoffw

VOLUME: 39

Page Numbers: 871-5

Journal Abbreviation: Horm. Metab. Res.

ISSN: 0018-5043

DAY: 24

MONTH: 10

YEAR: 2007

The Combination of High Glucose and Advanced Glycation End-products (AGEs) Inhibits the Mineralization of Osteoblastic MC3T3-E1 Cells through Glucose-induced Increase in the Receptor for AGEs. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 177722

The Combination of High Glucose and Advanced Glycation End-products (AGEs) Inhibits the Mineralization of Osteoblastic MC3T3-E1 Cells through Glucose-induced Increase in the Receptor for AGEs. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: The Combination of High Glucose and Advanced Glycation End-products (AGEs) Inhibits the Mineralization of Osteoblastic MC3T3-E1 Cells through Glucose-induced Increase in the Receptor for AGEs. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for The Combination of High Glucose and Advanced Glycation End-products (AGEs) Inhibits the Mineralization of Osteoblastic MC3T3-E1 Cells through Glucose-induced Increase in the Receptor for AGEs.

AFFILIATION: 1Internal Medicine 1, Shimane University Faculty of Medicine, Izumo, Shimane, Japan.

Country: Germany

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Horm Metab Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

The Combination of High Glucose and Advanced Glycation End-products AGEs Inhibits the Mineralization of Osteoblastic MC3T3-E1 Cells through Glucose-induced Increase in the Receptor for AGEs Related Publications

• A multi-fluorescent MDA435 cell line for mitosis inhibitor studies: simultaneous visualization of chromatin, microtubules, and nuclear envelope in living cells.
• A novel vacuolar myopathy with dilated cardiomyopathy.
• Altered prephenate dehydratase in phenylalanine-excreting mutants of Brevibacterium flavum.
• Altered regulatory mechanisms for tryptophan synthesis in fluorotryptophan-resistant mutants of Brevibacterium flavum.
• Complete deficiency of 5'-nucleotidase activity in Escherichia coli leads to loss of growth on purine nucleotides but not of their excretion.
• Conformational switch of a functional nanowire based on the DNA G-quadruplex.
• Dynamic behavior of FCHO1 revealed by live-cell imaging microscopy: its possible involvement in clathrin-coated vesicle formation.
• Dynamic properties of human eyes.
• Early rheumatoid arthritis in a patient with Sjögren's syndrome and pulmonary nodular amyloidosis: clinical implication of early limited use of infliximab.
• Effect of enzyme concentration on regulation of dissociable chorismate mutase in Brevibacterium flavum.
• Effects of cosolutes on the thermodynamic stability of parallel DNA duplex and triplex.
• Estimation of the in vivo translational activity of rat liver mitochondria without use of an antibiotic.
• Functionalization of DNA by the base pair-mimic nucleosides.
• Hydration regulates the thermodynamic stability of DNA structures under molecular crowding conditions.
• MPO-ANCA-positive IgA nephropathy successfully treated with tonsillectomy.
• Mitochondrial and cytosolic localization of a single glycerate kinase in rat kidney cortex.
• Purification of rat liver glycerate kinase and studies of its enzymatic and immunological properties.
• Retroviral integration site analysis and the fate of transduced clones in an MDR1 gene therapy protocol targeting metastatic breast cancer.
• Role of glucagon in increase of hepatic glycerate kinase of adult and neonatal rats.
• Serum insulin-like growth factor-I level is associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes mellitus.
• Synthesis and pharmacological profile of serofendic acids A and B.
• The Combination of High Glucose and Advanced Glycation End-products (AGEs) Inhibits the Mineralization of Osteoblastic MC3T3-E1 Cells through Glucose-induced Increase in the Receptor for AGEs.
• The Edg family G protein-coupled receptors for lysophospholipids: their signaling properties and biological activities.
• The base-pairing ability of the base pair-mimic nucleosides.
• The reduction of proprioceptors in the mesencephalic trigeminal tract nucleus after neonatal masseteric nerve transection; effect of brain-derived neurotrophic factor.
• The uraemic toxin phenylacetic acid inhibits osteoblastic proliferation and differentiation: an implication for the pathogenesis of low turnover bone in chronic renal failure.
• Two components of chorismate mutase in Brevibacterium flavum.
• Understanding eye deformation in non-contact tonometry.
• [Impaired bone mineralization in calcium-sensing receptor (CaSR) knockout mice : the physiological action of CaSR in bone microenvironments]
• [Transcriptional regulation of CTP: phosphocholine cytidylyltransferase alpha in phospholipid biosynthesis]